Exercise and Cognition Among Stroke Survivors

NCT ID: NCT06848998

Last Updated: 2025-02-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-19

Study Completion Date

2020-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to: (1) identify a suitable cardiopulmonary exercise testing protocol for people with moderate to severe movement impairments after stroke by investigating the safety and feasibility of delivering two methods of CPET modes: treadmill with body-weight support (TBWS) and cycle ergometry (CE); and (2) explore the safety and feasibility of a delivering a 6-week exercise-based intervention or people with moderate to severe movement impairments after stroke, with a view to improve cognitive health.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aerobic Exercise Resistance Exercise

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aerobic exercise

Group Type EXPERIMENTAL

aerobic exercise

Intervention Type BEHAVIORAL

40 minutes of aerobic exercise, twice per week for six weeks.

Sessions comprised of the following: 10-minute warm-up, 40-minute conditioning period as a circuit, and 10-minute cool-down.

Aerobic exercises (for example, recumbent cycling, stepping, arm crank) commenced at an intensity of 40-50% heart rate reserve (HRR) and increased incrementally by 10% as tolerated, up to a maximum of 70-80%. All sessions were individually tailored as far as possible to participants' needs, abilities, and preferences.

Resistance exercise

Group Type ACTIVE_COMPARATOR

Resistance exercise

Intervention Type BEHAVIORAL

4 x resistance exercises (3 sets of 6 repetitions), twice per week for six weeks.

Strengthening exercises (for example, resistance band work) were prescribed at an intensity that corresponded to 11-12 and incrementally increased to a maximum of 14-15, as tolerated, on the Borg Ratings of Perceived Exertion (RPE) 6-20 Scale. All sessions were individually tailored as far as possible to participants' needs, abilities, and preferences.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Resistance exercise

4 x resistance exercises (3 sets of 6 repetitions), twice per week for six weeks.

Strengthening exercises (for example, resistance band work) were prescribed at an intensity that corresponded to 11-12 and incrementally increased to a maximum of 14-15, as tolerated, on the Borg Ratings of Perceived Exertion (RPE) 6-20 Scale. All sessions were individually tailored as far as possible to participants' needs, abilities, and preferences.

Intervention Type BEHAVIORAL

aerobic exercise

40 minutes of aerobic exercise, twice per week for six weeks.

Sessions comprised of the following: 10-minute warm-up, 40-minute conditioning period as a circuit, and 10-minute cool-down.

Aerobic exercises (for example, recumbent cycling, stepping, arm crank) commenced at an intensity of 40-50% heart rate reserve (HRR) and increased incrementally by 10% as tolerated, up to a maximum of 70-80%. All sessions were individually tailored as far as possible to participants' needs, abilities, and preferences.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have provided informed consent,
* Are aged \>18 years,
* Are more than 6 months post-stroke,
* Score 2-3 on the Functional Ambulation Category
* Can follow 1-stage commands i.e. sufficient communication/orientation for interventions in the trial.

Exclusion Criteria

* Attending any other community exercise class/gym/walking group/rehabilitation class,
* A previous diagnosis of dementia or any other significant cognitive decline,
* Any musculoskeletal or neurophysiological disorder preventing participation in exercise,
* Have uncontrolled hypertension, atrial fibrillation, heart failure or diabetes.
* Weigh over 250lbs/113kg (due to weight restrictions on body-weight support harness on treadmill),
* Meeting any absolute or relative contraindication to exercise from American College of Sports Medicine (ACSM)

Contraindications to Exercise 2014, see below:

Absolute contraindications to exercise:

* A recent significant change in the resting ECG suggesting significant ischaemia, recent myocardial infarction (within 2 days) or other acute cardiac event
* Unstable angina
* Uncontrolled cardiac dysrhythmias causing symptoms or hemodynamic compromise
* Symptomatic severe aortic stenosis
* Uncontrolled symptomatic heart failure
* Actuate pulmonary embolus or pulmonary infarction
* Acute myocarditis or pericarditis
* Suspected or know dissecting aneurysm
* Acute systematic infection, accompanied by fever, body aches or swollen lymph glands

Relative contraindications to exercise:

* Left main coronary stenosis
* Moderate stenotic valvular heart disease
* Electrolyte abnormalities e.g. hypokalaemia, hypo-magnesia
* Severe arterial hypertensions i.e. systolic BP of \>200mmHg and/or diastolic BP of \>110mmHg at rest
* Tachydysrthythmia or bradydsrhythmia
* Hypertrophic cardiomyopathy and other forms of outflow tract obstruction
* Neuromuscular, musculoskeletal or rheumatoid disorders that are exacerbated by exercise
* High-degree atrioventricular block
* Ventricular aneurysm
* Uncontrolled metabolic disease e.g. diabetes, thyrotoxosis or myxedemia Chronic infectious diseases e.g. mononucleosis, hepatitis, AIDs
* Mental or physical impairment leading to inability to exercise adequately
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Leeds Beckett University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of East Anglia

Norwich, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17/EE/0409

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Combined Exercise Trial
NCT04848038 ACTIVE_NOT_RECRUITING NA
Exercise and RIC and TCD
NCT03968068 COMPLETED NA
The Lifestyle Exercise and Diet Trial (LEAD) 2.0
NCT06078748 ACTIVE_NOT_RECRUITING NA